Search





Search





Markets
/
Stocks
/
prme
/

Prime Medicine Inc

PRME

Add to Watchlist

3.015USD

+0.065+2.20%

Close 07-27 16:00（ET）Quotes delayed by 15 min

544.56MMarket Cap

LossP/E TTM

Prime Medicine Inc

3.015

+0.065+2.20%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

PRME Income Statement

You can find the annual or quarterly income statement of Prime Medicine Inc here for insights into the performance and operational efficiency of Prime Medicine Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

Total revenue

-41.13%856.00K

-61.61%838.00K

486.12%1.23M

--1.11M

146.02%1.45M

--2.18M

--209.00K

--0.00

--591.00K

----

--0.00

----

--0.00

Revenue

-41.13%856.00K

-61.61%838.00K

486.12%1.23M

--1.11M

146.02%1.45M

--2.18M

--209.00K

--0.00

--591.00K

----

--0.00

----

--0.00

Operating expenses

-4.34%51.51M

6.55%49.45M

1.39%55.20M

-2.12%54.49M

10.04%53.85M

-31.80%46.41M

5.79%54.44M

23.01%55.67M

22.23%48.93M

75.89%68.04M

62.56%51.46M

72.05%45.26M

101.19%40.03M

-35.60%38.69M

203.59%31.66M

228.16%26.30M

234.14%19.90M

2213.28%60.08M

--10.43M

--8.02M

--5.96M

--2.60M

R&D expenses

-15.92%34.10M

1.77%34.71M

9.05%43.99M

-3.94%41.38M

7.38%40.56M

-17.74%34.10M

-1.53%40.34M

24.49%43.07M

22.33%37.77M

42.66%41.46M

63.56%40.97M

82.68%34.60M

125.78%30.88M

-45.05%29.06M

238.47%25.05M

232.57%18.94M

199.54%13.68M

4100.87%52.89M

--7.40M

--5.70M

--4.57M

--1.26M

Depreciation, depletion, and amortization

9.18%1.86M

9.26%1.88M

20.73%1.88M

21.20%1.86M

29.28%1.70M

37.69%1.72M

26.05%1.56M

37.57%1.54M

25.00%1.31M

43.33%1.25M

95.88%1.24M

160.00%1.12M

259.04%1.05M

190.00%870.00K

277.84%631.00K

252.46%430.00K

193.00%293.00K

1204.35%300.00K

--167.00K

--122.00K

--100.00K

--23.00K

Other operating expenses

----

--13.50M

----

Operating profit

3.32%-50.65M

-9.92%-48.61M

0.48%-53.97M

4.12%-53.38M

-8.38%-52.39M

35.01%-44.22M

-5.39%-54.23M

-23.01%-55.67M

-20.75%-48.34M

-75.89%-68.04M

-62.56%-51.46M

-72.05%-45.26M

-101.19%-40.03M

35.60%-38.69M

-203.59%-31.66M

-228.16%-26.30M

-234.14%-19.90M

-2213.28%-60.08M

---10.43M

---8.02M

---5.96M

---2.60M

Net non-operating interest income (expenses)

Non-operating interest income

-13.62%1.02M

-29.58%1.08M

63.70%1.14M

21.60%743.00K

--1.18M

--1.54M

--697.00K

--611.00K

----

Gains from sale of securities

35.69%460.00K

180.39%858.00K

-15.03%752.00K

-64.33%530.00K

--339.00K

--306.00K

--885.00K

--1.49M

----

Special income (expenses)

100.00%0.00

813.56%539.00K

576.28%1.45M

73.77%-505.00K

-190.57%-1.06M

-90.71%59.00K

113.62%215.00K

-831.94%-1.93M

168.55%1.17M

137.16%635.00K

-188.26%-1.58M

107.06%263.00K

62.07%-1.70M

-16.58%-1.71M

121.41%1.79M

-138.19%-3.72M

94.48%-4.49M

-209.08%-1.47M

---8.35M

--9.75M

---81.32M

--1.34M

Other non-operating income (expenses)

37.84%51.00K

13.95%49.00K

153.01%44.00K

-53.85%18.00K

-97.61%37.00K

-97.56%43.00K

-103.74%-83.00K

-98.52%39.00K

-27.49%1.55M

90.60%1.77M

205.22%2.22M

1009.24%2.64M

19309.09%2.13M

7616.67%926.00K

72900.00%728.00K

23700.00%238.00K

--11.00K

-97.84%12.00K

---1.00K

--1.00K

--0.00

--555.00K

Income before tax

5.33%-49.12M

-9.00%-46.08M

3.69%-50.58M

5.17%-52.59M

-13.73%-51.89M

35.60%-42.28M

-3.35%-52.52M

-30.95%-55.46M

-15.22%-45.63M

-66.32%-65.64M

-74.40%-50.82M

-42.18%-42.35M

-62.48%-39.60M

35.85%-39.47M

-55.14%-29.14M

-1817.99%-29.79M

72.07%-24.37M

-8715.19%-61.53M

---18.78M

--1.73M

---87.28M

---698.00K

Income tax

----

100.00%0.00

-100.00%0.00

--0.00

100.00%0.00

-532.26%-134.00K

166.34%134.00K

100.00%0.00

-150.94%-108.00K

107.01%31.00K

62.03%-202.00K

-113.47%-186.00K

108.95%212.00K

-139.53%-442.00K

13.50%-532.00K

-26.03%1.38M

---2.37M

--1.12M

---615.00K

--1.87M

Income after tax

5.33%-49.12M

-9.00%-46.08M

3.69%-50.58M

4.95%-52.59M

-13.39%-51.89M

35.60%-42.28M

-3.57%-52.52M

-30.53%-55.33M

-16.15%-45.76M

-67.10%-65.64M

-72.77%-50.71M

-44.42%-42.38M

-65.26%-39.40M

37.56%-39.28M

-78.83%-29.35M

-4864.29%-29.35M

72.49%-23.84M

-2352.67%-62.91M

---16.41M

--616.00K

---86.66M

---2.56M

Net income from continuous operations

5.33%-49.12M

-9.00%-46.08M

3.69%-50.58M

4.95%-52.59M

-13.39%-51.89M

35.60%-42.28M

-3.57%-52.52M

-30.53%-55.33M

-16.15%-45.76M

-67.10%-65.64M

-72.77%-50.71M

-44.42%-42.38M

-65.26%-39.40M

37.56%-39.28M

-78.83%-29.35M

-4864.29%-29.35M

72.49%-23.84M

-2352.67%-62.91M

---16.41M

--616.00K

---86.66M

---2.56M

Net income attributable to controlling interests

5.33%-49.12M

-9.00%-46.08M

3.69%-50.58M

4.95%-52.59M

-13.39%-51.89M

35.60%-42.28M

-3.57%-52.52M

-30.53%-55.33M

-16.15%-45.76M

-61.69%-65.64M

-41.99%-50.71M

-18.92%-42.38M

-31.04%-39.40M

41.40%-40.60M

-56.80%-35.71M

-745.17%-35.64M

65.78%-30.06M

-1970.32%-69.27M

---22.77M

---4.22M

---87.85M

---3.35M

Preferred share dividend

----

-100.00%0.00

-79.35%1.31M

-0.02%6.36M

30.21%6.29M

421.27%6.22M

714.60%6.36M

--6.36M

--4.83M

--1.19M

--781.00K

Net income attributable to common shareholders

5.33%-49.12M

-9.00%-46.08M

3.69%-50.58M

4.95%-52.59M

-13.39%-51.89M

35.60%-42.28M

-3.57%-52.52M

-30.53%-55.33M

-16.15%-45.76M

-61.69%-65.64M

-41.99%-50.71M

-18.92%-42.38M

-31.04%-39.40M

41.40%-40.60M

-56.80%-35.71M

-745.17%-35.64M

65.78%-30.06M

-1970.32%-69.27M

---22.77M

---4.22M

---87.85M

---3.35M

Basic earnings per share

30.04%-0.28

19.51%-0.26

28.13%-0.32

12.30%-0.41

9.49%-0.40

54.51%-0.32

20.57%-0.44

0.92%-0.46

0.97%-0.44

-85.06%-0.71

-45.84%-0.55

-24.01%-0.47

-38.80%-0.44

47.76%-0.38

-56.81%-0.38

-745.21%-0.38

65.78%-0.32

-1970.26%-0.73

---0.24

---0.04

---0.93

---0.04

Diluted earnings per share

30.04%-0.28

19.51%-0.26

28.13%-0.32

12.30%-0.41

9.49%-0.40

54.51%-0.32

20.57%-0.44

0.92%-0.46

0.97%-0.44

-85.06%-0.71

-45.84%-0.55

-24.01%-0.47

-38.80%-0.44

47.76%-0.38

-56.81%-0.38

-745.21%-0.38

65.78%-0.32

-1970.26%-0.73

---0.24

---0.04

---0.93

---0.04

Dividend per share

--0.00

Currency unit

--USD

Audit opinions

----

FAQs

How do I read Prime Medicine Inc's income statement on TradingKey?



Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?



A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?



YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing PRME stock?



Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Prime Medicine Inc's revenue at year end?



Prime Medicine Inc reported 4.63M in revenue for fiscal year 2025, up from 2.98M in the previous year.

How much revenue did Prime Medicine Inc report in the most recent quarter?



Prime Medicine Inc reported 856.00K in revenue for the most recent quarter, an increase of -41.13% year over year.

What was Prime Medicine Inc's net income for the year?



Prime Medicine Inc posted -201.14M in net income for fiscal year 2025.

How much net income did Prime Medicine Inc post in the last quarter?



Prime Medicine Inc reported -49.12M in net income for the latest quarter。

What was Prime Medicine Inc's annual operating profit?



Prime Medicine Inc's operating income was -208.35M for fiscal year 2025.

How is EPS related to the income statement?



EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.